Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: Benefits, risks and outcome

G. Pavesi, A. Feletti, S. Berlucchi, G. Opocher, M. Martella, A. Murgia, R. Scienza

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Aim. Von Hippel-Lindau (VHL) disease is a genetic syndrome predisposing to central nervous system (CNS) hemangioblastomas and several lesions in many organs. The cases of all VHL individuals operated on in the Neurosurgical Unit of Padua Hospital since year 2000 were reviewed in order to define which features lead to surgical treatment and to examine surgical outcome during postoperative follow-up. Methods. The authors evaluated 20 VHL subjects (7 males and 13 females, age at surgery 32±10 years) who underwent 28 operations in order to remove 48 CNS hemangioblastomas and 1 endolymphatic sac tumor. Among the 49 resected lesions, 21 (42%) were cerebellar, 9 (18%) at brainstem, 19 (38%) spinal (7 cervical, 6 dorsal, 6 at cone-cauda level), and 1 (2%) endolymphatic sac tumor in the petrous bone. Patients were graduated according to Karnofsky Performance Status (KPS) at admission, at discharge and during the last follow up visit. Genetic testing revealing the presence of a VHL disease-causing mutation was a prerequisite for inclusion in the study. Results. Nineteen individuals (95%) were symptomatic. Symptomatic hemangioblastomas were associated with a cyst or a syrinx in 22/27 circumstances (81%). Total removal, as confirmed by postoperative magnetic resonance imaging (MRI), was achieved in all but one lesion. Following surgery, at follow-up (38±20 months), patients improved their neurological status in 75% of cases, 20% remained stable and 5% worsened; 16 patients (80%) are able to carry on normal activity with or without minor symptoms, 3 patients require some grade of assistance, 1 patient died because of bronchopneumonia. Conclusion. VHL-associated hemangioblastomas generally affect a young adult population and can be successfully removed, either when symptomatic, or when they reach a critical volume. Microsurgery of hemangioblastomas has a favourable impact on survival and quality of life of VHL patients, although it is strongly influenced by preoperative conditions. Transient surgical complications are possible, particularly with brainstem and spinal cord hemangioblastomas.

Original languageEnglish
Pages (from-to)29-36
Number of pages8
JournalJournal of Neurosurgical Sciences
Volume52
Issue number2
Publication statusPublished - Jun 2008

Fingerprint

Hemangioblastoma
Endolymphatic Sac
von Hippel-Lindau Disease
Brain Stem
Therapeutics
Central Nervous System
Petrous Bone
Karnofsky Performance Status
Bronchopneumonia
Hospital Units
Microsurgery
Syringes
Genetic Testing
Cysts
Young Adult
Neoplasms
Spinal Cord
Quality of Life
Magnetic Resonance Imaging
Mutation

Keywords

  • Hemangioblastoma
  • Microsurgery
  • Neoplasm
  • Von Hippel-Lindau disease

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Pavesi, G., Feletti, A., Berlucchi, S., Opocher, G., Martella, M., Murgia, A., & Scienza, R. (2008). Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: Benefits, risks and outcome. Journal of Neurosurgical Sciences, 52(2), 29-36.

Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas : Benefits, risks and outcome. / Pavesi, G.; Feletti, A.; Berlucchi, S.; Opocher, G.; Martella, M.; Murgia, A.; Scienza, R.

In: Journal of Neurosurgical Sciences, Vol. 52, No. 2, 06.2008, p. 29-36.

Research output: Contribution to journalArticle

Pavesi, G, Feletti, A, Berlucchi, S, Opocher, G, Martella, M, Murgia, A & Scienza, R 2008, 'Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: Benefits, risks and outcome', Journal of Neurosurgical Sciences, vol. 52, no. 2, pp. 29-36.
Pavesi, G. ; Feletti, A. ; Berlucchi, S. ; Opocher, G. ; Martella, M. ; Murgia, A. ; Scienza, R. / Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas : Benefits, risks and outcome. In: Journal of Neurosurgical Sciences. 2008 ; Vol. 52, No. 2. pp. 29-36.
@article{168fed96ea5e47f380d78ed031e831ae,
title = "Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas: Benefits, risks and outcome",
abstract = "Aim. Von Hippel-Lindau (VHL) disease is a genetic syndrome predisposing to central nervous system (CNS) hemangioblastomas and several lesions in many organs. The cases of all VHL individuals operated on in the Neurosurgical Unit of Padua Hospital since year 2000 were reviewed in order to define which features lead to surgical treatment and to examine surgical outcome during postoperative follow-up. Methods. The authors evaluated 20 VHL subjects (7 males and 13 females, age at surgery 32±10 years) who underwent 28 operations in order to remove 48 CNS hemangioblastomas and 1 endolymphatic sac tumor. Among the 49 resected lesions, 21 (42{\%}) were cerebellar, 9 (18{\%}) at brainstem, 19 (38{\%}) spinal (7 cervical, 6 dorsal, 6 at cone-cauda level), and 1 (2{\%}) endolymphatic sac tumor in the petrous bone. Patients were graduated according to Karnofsky Performance Status (KPS) at admission, at discharge and during the last follow up visit. Genetic testing revealing the presence of a VHL disease-causing mutation was a prerequisite for inclusion in the study. Results. Nineteen individuals (95{\%}) were symptomatic. Symptomatic hemangioblastomas were associated with a cyst or a syrinx in 22/27 circumstances (81{\%}). Total removal, as confirmed by postoperative magnetic resonance imaging (MRI), was achieved in all but one lesion. Following surgery, at follow-up (38±20 months), patients improved their neurological status in 75{\%} of cases, 20{\%} remained stable and 5{\%} worsened; 16 patients (80{\%}) are able to carry on normal activity with or without minor symptoms, 3 patients require some grade of assistance, 1 patient died because of bronchopneumonia. Conclusion. VHL-associated hemangioblastomas generally affect a young adult population and can be successfully removed, either when symptomatic, or when they reach a critical volume. Microsurgery of hemangioblastomas has a favourable impact on survival and quality of life of VHL patients, although it is strongly influenced by preoperative conditions. Transient surgical complications are possible, particularly with brainstem and spinal cord hemangioblastomas.",
keywords = "Hemangioblastoma, Microsurgery, Neoplasm, Von Hippel-Lindau disease",
author = "G. Pavesi and A. Feletti and S. Berlucchi and G. Opocher and M. Martella and A. Murgia and R. Scienza",
year = "2008",
month = "6",
language = "English",
volume = "52",
pages = "29--36",
journal = "Journal of Neurosurgical Sciences",
issn = "0026-4881",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Neurosurgical treatment of von Hippel-Lindau-associated hemangioblastomas

T2 - Benefits, risks and outcome

AU - Pavesi, G.

AU - Feletti, A.

AU - Berlucchi, S.

AU - Opocher, G.

AU - Martella, M.

AU - Murgia, A.

AU - Scienza, R.

PY - 2008/6

Y1 - 2008/6

N2 - Aim. Von Hippel-Lindau (VHL) disease is a genetic syndrome predisposing to central nervous system (CNS) hemangioblastomas and several lesions in many organs. The cases of all VHL individuals operated on in the Neurosurgical Unit of Padua Hospital since year 2000 were reviewed in order to define which features lead to surgical treatment and to examine surgical outcome during postoperative follow-up. Methods. The authors evaluated 20 VHL subjects (7 males and 13 females, age at surgery 32±10 years) who underwent 28 operations in order to remove 48 CNS hemangioblastomas and 1 endolymphatic sac tumor. Among the 49 resected lesions, 21 (42%) were cerebellar, 9 (18%) at brainstem, 19 (38%) spinal (7 cervical, 6 dorsal, 6 at cone-cauda level), and 1 (2%) endolymphatic sac tumor in the petrous bone. Patients were graduated according to Karnofsky Performance Status (KPS) at admission, at discharge and during the last follow up visit. Genetic testing revealing the presence of a VHL disease-causing mutation was a prerequisite for inclusion in the study. Results. Nineteen individuals (95%) were symptomatic. Symptomatic hemangioblastomas were associated with a cyst or a syrinx in 22/27 circumstances (81%). Total removal, as confirmed by postoperative magnetic resonance imaging (MRI), was achieved in all but one lesion. Following surgery, at follow-up (38±20 months), patients improved their neurological status in 75% of cases, 20% remained stable and 5% worsened; 16 patients (80%) are able to carry on normal activity with or without minor symptoms, 3 patients require some grade of assistance, 1 patient died because of bronchopneumonia. Conclusion. VHL-associated hemangioblastomas generally affect a young adult population and can be successfully removed, either when symptomatic, or when they reach a critical volume. Microsurgery of hemangioblastomas has a favourable impact on survival and quality of life of VHL patients, although it is strongly influenced by preoperative conditions. Transient surgical complications are possible, particularly with brainstem and spinal cord hemangioblastomas.

AB - Aim. Von Hippel-Lindau (VHL) disease is a genetic syndrome predisposing to central nervous system (CNS) hemangioblastomas and several lesions in many organs. The cases of all VHL individuals operated on in the Neurosurgical Unit of Padua Hospital since year 2000 were reviewed in order to define which features lead to surgical treatment and to examine surgical outcome during postoperative follow-up. Methods. The authors evaluated 20 VHL subjects (7 males and 13 females, age at surgery 32±10 years) who underwent 28 operations in order to remove 48 CNS hemangioblastomas and 1 endolymphatic sac tumor. Among the 49 resected lesions, 21 (42%) were cerebellar, 9 (18%) at brainstem, 19 (38%) spinal (7 cervical, 6 dorsal, 6 at cone-cauda level), and 1 (2%) endolymphatic sac tumor in the petrous bone. Patients were graduated according to Karnofsky Performance Status (KPS) at admission, at discharge and during the last follow up visit. Genetic testing revealing the presence of a VHL disease-causing mutation was a prerequisite for inclusion in the study. Results. Nineteen individuals (95%) were symptomatic. Symptomatic hemangioblastomas were associated with a cyst or a syrinx in 22/27 circumstances (81%). Total removal, as confirmed by postoperative magnetic resonance imaging (MRI), was achieved in all but one lesion. Following surgery, at follow-up (38±20 months), patients improved their neurological status in 75% of cases, 20% remained stable and 5% worsened; 16 patients (80%) are able to carry on normal activity with or without minor symptoms, 3 patients require some grade of assistance, 1 patient died because of bronchopneumonia. Conclusion. VHL-associated hemangioblastomas generally affect a young adult population and can be successfully removed, either when symptomatic, or when they reach a critical volume. Microsurgery of hemangioblastomas has a favourable impact on survival and quality of life of VHL patients, although it is strongly influenced by preoperative conditions. Transient surgical complications are possible, particularly with brainstem and spinal cord hemangioblastomas.

KW - Hemangioblastoma

KW - Microsurgery

KW - Neoplasm

KW - Von Hippel-Lindau disease

UR - http://www.scopus.com/inward/record.url?scp=47949104445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47949104445&partnerID=8YFLogxK

M3 - Article

C2 - 18500215

AN - SCOPUS:47949104445

VL - 52

SP - 29

EP - 36

JO - Journal of Neurosurgical Sciences

JF - Journal of Neurosurgical Sciences

SN - 0026-4881

IS - 2

ER -